SCHEMBL9601728

SCHEMBL9601728

O=C(Nc1nccs1)c1c(C(O)CO)nc2ccc(C(F)(F)F)cc2c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.51
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SCN5A Q14524 1/20 0.40
MAPT P10636 2/20 0.39
ADORA2A P29274 2/20 0.39
POLB P06746 1/20 0.39
ESR2 Q92731 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP2C19 P33261 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3C2B O00750 1/20 0.38
AURKA O14965 1/20 0.38
PIK3C2G O75747 1/20 0.38
CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11125875 0.88 ALDH1A1 (0.43) SCN9AALDH1A1NPC1RAB9AMAPT
SCHEMBL9601963 0.87 ALDH1A1 (0.43) SCN9AALDH1A1NPC1RAB9AMAPT
SCHEMBL11148451 0.84 NPC1 (0.45) SCN9AALDH1A1NPC1RAB9AMAPT
SCHEMBL9603052 0.83 SCN9A (0.39) SCN9AALDH1A1NPC1RAB9AADORA2A
SCHEMBL10518997 0.81 ADORA2A (0.42) SCN9AALDH1A1NPC1RAB9AADORA2A
SCHEMBL9605099 0.80 KCNMA1 (0.49) ALDH1A1NPC1RAB9AMAPTPOLB
SCHEMBL9601722 0.80 SCN9A (0.45) SCN9AALDH1A1NPC1RAB9AMAPT
SCHEMBL11200589 0.76 NPC1 (0.43) SCN9AALDH1A1NPC1RAB9AMAPT
SCHEMBL11617695 0.76 ALDH1A1 (0.47) SCN9AALDH1A1NPC1RAB9AMAPT
SCHEMBL11208407 0.73 ALDH1A1 (0.45) ALDH1A1NPC1RAB9AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214004-B1 4-OH-QUINOLINE-CARBOXYLIC-ACID DERIVATIVES SUBSTITUTED IN POSITION 2 BY A DIHYDROXY-SUBSTITUTED GROUP, POSSIBLY ETHERIFIED OR ESTERIFIED, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1993-03-31 EP claimed